Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”
Joint Authors
Navakauskiene, Ruta
Vitkevičienė, Aida
Skiauterytė, Giedrė
Žučenka, Andrius
Stoškus, Mindaugas
Gineikienė, Eglė
Borutinskaitė, Veronika
Griškevičius, Laimonas
Source
Issue
Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-1, 1 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2020-09-04
Country of Publication
Egypt
No. of Pages
1
Main Subjects
Abstract EN
In the article titled “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia” [1], the last author was mistakenly linked to the second affiliation instead of the first.
The corrected author list and affiliations are shown above.
American Psychological Association (APA)
Vitkevičienė, Aida& Skiauterytė, Giedrė& Žučenka, Andrius& Stoškus, Mindaugas& Gineikienė, Eglė& Borutinskaitė, Veronika…[et al.]. 2020. Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”. Journal of Oncology،Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1188858
Modern Language Association (MLA)
Vitkevičienė, Aida…[et al.]. Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”. Journal of Oncology No. 2020 (2020), pp.1-1.
https://search.emarefa.net/detail/BIM-1188858
American Medical Association (AMA)
Vitkevičienė, Aida& Skiauterytė, Giedrė& Žučenka, Andrius& Stoškus, Mindaugas& Gineikienė, Eglė& Borutinskaitė, Veronika…[et al.]. Corrigendum to “HDAC and HMT Inhibitors in Combination with Conventional Therapy: A Novel Treatment Option for Acute Promyelocytic Leukemia”. Journal of Oncology. 2020. Vol. 2020, no. 2020, pp.1-1.
https://search.emarefa.net/detail/BIM-1188858
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1188858
